Repligen (RGEN) gains support from Q1 demand in analytics, consumables

Repligen Corp. (RGEN) reported first-quarter results that were positively received by investors, driven by growth across core product lines and stronger demand in analytics and consumables. Management said analytics revenue rose more than 50%, with all franchises posting growth. CEO Olivier Loeillot cited a recovery in capital equipment demand and improving order trends, while Asia Pacific, particularly China, showed notable momentum. The company also benefited from the divestiture of its lower-margin Polymem business and continued cost controls, which supported margin improvement. Shares recently traded at $118.50, little changed from $118.21 before the earnings report.